Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 30, 1998
Grant Date -
N/A
app pub date -
Oct 23, 1995
filing date -
Oct 23, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Restenosis in recanalized blood vessels is inhibited by delivering tissue factor pathway inhibitor (TFPI) intramurally at a target site within the blood vessel. Usually, TFPI is delivered using a catheter having infusion ports at its distal end. Optionally at the distal end of the catheter is radially expanded to engage the infusion ports directly against the blood vessel wall.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully